Image (05c71afa 5724 46ea B841 Eb124e2e4130 01)
Droxidopa Capsule
Product Images NDC 70710-1389
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 70710-1389). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (05c71afa 5724 46ea B841 Eb124e2e4130 02)
Droxidopa is a medication for which there is a report showing the mean change in dizziness over a period of 8 weeks during its double-blind treatment phase. The data is presented in a table where the baseline value is compared with the values obtained at weeks 1 to 8. The value of the mean change is equal to 35, but there is no further context or explanation provided to interpret this value.*
Image (05c71afa 5724 46ea B841 Eb124e2e4130 03)
Image (05c71afa 5724 46ea B841 Eb124e2e4130 04)
This is the description for a medication called Droxidopa Capsules. Each capsule contains 100 mg of droxidopa and comes in a child-resistant package. The recommended dosage can be found in the package insert. It should be stored at a temperature between 20°C to 25°C, with permitted excursions to 15°C to 30°C. The medication should be dispensed in a light-resistant container, and if the printed seal under the cap is broken or missing, it should not be used. This drug should be kept out of reach of children. The manufacturer is Cadila Healthcare Ltd located in Ahmedabad, India, and the product is distributed by Zydus Pharmaceuticals (USA) in Pennington, NJ.*
Image (05c71afa 5724 46ea B841 Eb124e2e4130 05)
This is a description of a medication called droxidopa. Each capsule contains 200 mg of droxidopa. The usual dosage is provided in the package insert. The medication should be stored at 20°C to 25°C. It should be kept out of reach of children and dispensed in a tight, light-resistant container. The manufacturer is Cacila Healthcare Lid in Abmedabad, India, and it is distributed by Zydus Pharmaceuticals (USA) in Pennington, NJ.*
Image (05c71afa 5724 46ea B841 Eb124e2e4130 06)
This is a prescription drug capsule manufactured in Abmedabad, India by Zydus Pharmaceuticals (USA) Inc. Each capsule contains 300 mg of droxidopa. This drug is stored at 20°C to 25°C (68°F to 77°F) within a tight, light-resistant container, with 90 capsules distributed. Please refer to the package insert for complete prescribing information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
